Global Respiratory Care Devices Market Outlook, 2028

Global Respiratory Care Devices Market Outlook, 2028

Respiratory diseases are among the most common non-communicable diseases worldwide, largely due to the ubiquity of noxious environmental, occupational, and behavioral inhalational exposures. In addition to chronic obstructive pulmonary disease (COPD) and asthma, chronic respiratory diseases include interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis, such as silicosis and asbestosis. Unfortunately, respiratory diseases have received proportionately less public attention and less research funding than other disease entities such as cardiovascular disease, cancer, stroke, diabetes, and Alzheimer's disease. According to NDC Alliance, globally, respiratory diseases affect at least 550 million adults, although estimates range up to 1 billion, and account for at least 7% of all deaths worldwide (4.2 million deaths). Lung cancer adds to this number another 1.4 million deaths annually (2.4% of global deaths). Lung diseases in children under five years of age, counting both acute infectious diseases like pneumonia and chronic conditions like asthma, are among the most common causes of death. Asthma is the most common chronic condition, affecting about 14% of children globally with rising prevalence. This has increased the focus of healthcare professional towards the respiratory care devices with the advance technology to cure it. Respiratory care devices have seen continuous advancements and innovations in recent years. ISO 18562 is a series of standards that outlines the general principles for the evaluation of breathing gas pathways of medical devices used in respiratory care or to supply anesthesia or other substances through the respiratory tract. The key trends for the increased market of respiratory care devices includes the rising med-tech research and development expenditure, accelerating smart inhaler industry, technological advancements in ventilators, increasing use of AI to develop respiratory devices to treat Asthma and COPD, Increasing presence in home care settings, and Growth from product innovations.

According to the research report, “Global Respiratory Care Devices Market Outlook, 2028” published by Bonafide Research, the market is anticipated to cross USD 35 Billion by 2028, increasing from USD 22.94 Billion in 2022. The market is expected to grow with 7.86% CAGR by 2023-28. The global respiratory care devices market is experiencing a substantial and sustained expansion, driven by a confluence of factors that underscore the critical importance of respiratory health in the modern world. With the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, there is an increasing demand for advanced and innovative solutions to manage and treat these conditions effectively. Furthermore, the ongoing challenges posed by environmental factors like air pollution and the respiratory complications arising from the COVID-19 pandemic have further accentuated the need for cutting-edge respiratory care devices. Technological advancements in the field have given rise to a diverse range of devices, including smart inhalers that improve medication adherence, high-flow nasal cannula systems that enhance oxygen delivery, and ventilators integrated with artificial intelligence for optimized patient care. Telemedicine integration and remote monitoring capabilities have become essential features, particularly in the wake of the pandemic, allowing healthcare providers to offer comprehensive care while minimizing physical contact. 3D printing technology has revolutionized the customization and production of respiratory devices, while nanotechnology has improved drug delivery, making treatment more efficient and precise. The demand for personalized and portable respiratory care devices, such as CPAP machines and oxygen concentrators, has surged as they offer patients greater mobility and convenience. Additionally, non-invasive ventilation masks with superior sealing capabilities and air purification systems have advanced patient comfort and respiratory health. As the respiratory care device market continues to grow, it plays a pivotal role in supporting the health and well-being of millions of individuals worldwide, and the ongoing research and innovation in this field promise even more breakthroughs in the near future to address the evolving needs of respiratory patients and healthcare professionals alike.

Based on the geography, the market is segmented into regions including North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the market, due to the presence of numerous research institutions, medical device manufacturers, and healthcare technology companies, fosters the development of cutting-edge respiratory care devices with advanced features and capabilities. In North America, the market was valued more than USD 7 Billion in 2022. There are a number of government initiatives in North America to support the use of respiratory care devices. These initiatives are designed to improve access to devices, reduce costs, and promote innovation. Medicare and Medicaid are the two largest government-funded health insurance programs in the United States. Both programs cover a wide range of respiratory care devices, including ventilators, oxygen concentrators, and nebulizers. The CDC provides a number of resources to support the use of respiratory care devices, including; The National Asthma Control Program, this program provides funding and technical assistance to states and communities to help them develop and implement asthma control programs and The Asthma Community Resource Center, this website provides information and resources to people with asthma and their families, including information about respiratory care devices. In addition to the initiatives listed above, some North American governments also offer specific programs and services to support people with respiratory diseases. For example, the Canadian government offers the Respiratory Health Program, which provides funding for respiratory care services and research. The US government also offers a number of programs to support people with respiratory diseases, including the National Asthma Management Program and the COPD National Action Plan. North America conducts a large percentage of global clinical studies, particularly those involving respiratory care devices. Because regulatory approvals frequently require significant clinical testing, this enables the entry of new and innovative products into the market. Medical tourists seeking advanced respiratory care treatments flock to the region. High-quality healthcare facilities, renowned medical professionals, and cutting-edge technologies make North America an appealing destination for people seeking respiratory care from all over the world.

The market is segmented based on the Product type to Therapeutic Devices, Monitoring Devices, Diagnostic Devices, and Consumables and Accessories. The global market for respiratory care devices was indeed dominated by therapeutic devices. Respiratory care devices are essential in managing a wide range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and more. Therapeutic devices play a crucial role in treating respiratory conditions and are often in high demand due to the prevalence of respiratory diseases. Some common therapeutic devices in this market include Inhalers, Ventilators, Positive Airways Pressure (PAP) Devices, Humidifiers, Nebulizers, and others (Oxygen Concentrators, oxygen Hood). The global population is aging rapidly, and older adults are more likely to develop chronic respiratory diseases. Inhalers and nebulizers are effective and convenient ways to deliver medication directly to the lungs. This makes them ideal for treating chronic respiratory diseases, as well as other conditions such as cystic fibrosis and pneumonia. Inhalers and nebulizers are becoming more widely available in both developed and developing countries. This is due to a number of factors, including the increasing number of manufacturers and the growing adoption of home healthcare. The report is categorized into Monitoring devices which include Pulse Oximeter and gas analyzers. The global market for pulse oximeters and gas analyzers has witnessed significant growth and diversification over the years, driven by various factors. Pulse oximeters, which are primarily used to measure oxygen saturation levels in the blood, have gained exceptional prominence, especially in light of the COVID-19 pandemic, as they offer a simple and non-invasive means to monitor respiratory health. This increased awareness and demand for pulse oximeters have propelled market expansion. Furthermore, the market for gas analyzers, devices employed to measure and analyze the composition of gases in various industrial processes and environmental applications, has also experienced substantial growth due to the need for precise data in sectors like petrochemicals, environmental monitoring, and healthcare. Technological advancements, such as the integration of wireless connectivity and data management systems, have enhanced the utility of both pulse oximeters and gas analyzers, contributing to their widespread adoption in healthcare facilities, laboratories, industrial settings, and even among consumers.

Based on the consumables and accessories of respiratory care devices, the market is further distinguished into Disposable Resuscitators, Breathing Circuits, Masks, Tracheostomy Tubes, and Others (Nasal Cannulas). In the global market for medical equipment, disposable resuscitators did hold a considerable market share. In emergency medical care, disposable resuscitators, also known as bag-valve masks, are essential, especially in instances where immediate ventilation support is needed, such as cardiac arrests, trauma cases, or respiratory distress conditions. There are a number of important variables that contribute to their market domination. The fact that these devices are disposable guarantees infection control and reduces the possibility of cross-contamination, two important considerations in hospital settings, particularly in light of the COVID-19 epidemic. They are also crucial tools for paramedics, first responders, and healthcare workers in a variety of clinical situations because to their portability and ease of use. Additionally, the emphases on disaster preparedness around the world and the requirement for trustworthy and cost-effective respiratory support devices have bolstered the demand for disposable resuscitators. Based on the diagnostics devices, the market is categorized into Spirometers, Polysomnography Devices, and Peak Flow meters. Spirometers are vital diagnostic tools used to measure lung function and airflow, making them essential for assessing various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases. The dominance of spirometers in this market can be attributed to their accuracy, ease of use, and widespread adoption in clinical settings, including hospitals, clinics, and primary care facilities. The ability to provide quantitative data on lung function, such as forced vital capacity (FVC) and forced expiratory volume (FEV1) makes spirometer a crucial tool for diagnosing and managing respiratory conditions.

The market is segmented based on the Disease into Chronic Obstructive Pulmonary disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Other disease Indications. According to World Health Organization, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing nearly 3.23 million deaths in 2019. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC). COPD is the seventh leading cause of poor health worldwide (measured by disability-adjusted life years). Tobacco smoking accounts for over 70% of COPD cases in high-income countries. In LMIC tobacco smoking accounts for 30–40% of COPD cases, and household air pollution is a major risk factor. The rising incidence of COPD has driven the global market for respiratory care devices. This trend is further reinforced by increased awareness of respiratory health, advancements in device technology, and a growing emphasis on early diagnosis and proactive management of respiratory diseases. As a result, the market for respiratory care devices has experienced significant growth, and it is expected to continue to expand as healthcare systems strive to meet the needs of patients with COPD and other respiratory conditions on a global scale.

The global market for respiratory care devices is diversified and dynamic, as shown by the market segmentation based on end-users, which includes hospitals; ambulatory care centers (ACCs), home care settings, and other end-users. Due primarily to the substantial usage of respiratory care devices in inpatient settings, hospitals unquestionably have the highest market share among these groups. In addition to treating a variety of respiratory ailments, including acute exacerbations of chronic illnesses like COPD and the urgent requirements of patients in emergency rooms, hospitals serve as the frontline of healthcare. Their widespread use is a result of the vital function that respiratory care devices play in these high-acuity situations, when prompt and accurate intervention can mean the difference between life and death. Given their function in delivering outpatient care, ambulatory care centers (ACCs) rank in second in terms of market share. In contrast to standard hospitalization, ACCs are outfitted with respiratory care equipment to better accommodate patients with a variety of respiratory diseases. These facilities are essential for managing chronic diseases, including routine examinations and treatments, and frequently use respiratory care equipment to track and assist patients with illnesses like asthma, bronchitis, and sleep apnea. Home care settings represent another significant segment in the market. The shift towards home-based healthcare has led to a surge in the use of respiratory care devices in a familiar and comfortable environment. Patients with chronic respiratory conditions benefit from devices like oxygen concentrators, nebulizers, and CPAP machines, which enable them to manage their conditions with ease while maintaining a better quality of life. The """"Other End User"""" category encompasses various healthcare facilities and providers beyond the primary three segments, including long-term care facilities, rehabilitation centers, and specialty clinics. These settings also contribute to the demand for respiratory care devices, albeit to a somewhat lesser extent.

Key Developments:

• In July 2022, Omron Healthcare launched a portable oxygen concentrator. The concentrator is based on a medical molecular sieve and provides a continuous supply of high-purity oxygen. It delivers 5 liters of oxygen per minute.

• In 2021, Medical devices maker Smiths Medical has introduced new acapella choice blue vibratory positive vibratory pressure (PEP) therapy system to facilitate the removal of secretions for patients who have cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

• During 2022, the Xplore Health Technologies has launched a first-of-its-kind respiratory muscle training (RTM) device called Airofit PRO, it is a smart breathing training device that uses resistance training to strengthen and increase the capacity of breathing muscles.

• On April 10, 2023, Compal Electronics, a Taiwanese electronics company, has launched a new radiofrequency ablation (RFA) system for percutaneous, intraoperative coagulation and ablation of soft tissue, including partial or complete ablation of non-resectable liver lesions and a Bilevel ventilator for chronic obstructive pulmonary disease and respiratory insufficiency caused by central and/or mixed apneas. It includes the AblatePal and BreathePal Ventilator in therapeutic medical device.

• In 2023, Vitalograph launched the VitaloPFT series at the Arab Health Exhibition. The VitaloPFT series was introduced to supply partners and healthcare professionals from all over the world. The series is being released globally in phases.

Competitive Landscape

Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG , GE HealthCare Technologies, Inc., Teleflex Incorporated, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited , Vapotherm Inc., Getinge AB, Dragerwerk AG & Co. KGaA, Invacare Corporation, Nidek Medical products Inc. , Precision Medical Inc, Teijin Pharma Limited, Besco Medical Limited

Market Drivers

Growing Respiratory Disorders: One of the foremost drivers propelling the global respiratory market is the alarming increase in the prevalence of respiratory disorders worldwide. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections are becoming increasingly common, primarily due to factors like air pollution, widespread smoking, and the aging of populations in many regions. The COVID-19 pandemic has further underscored the critical importance of respiratory care, emphasizing the urgent need for advanced respiratory equipment, treatments, and interventions. In response to this growing demand, healthcare providers and governments around the world are making significant investments in expanding respiratory care services, as well as in the adoption of innovative respiratory technologies to address the escalating need for the diagnosis, treatment, and management of various respiratory disorders. This surge in demand for respiratory care is driving the growth of the global respiratory market.

Technological Advancements: Technological advancements represent another major driving force in the global respiratory market. The development of cutting-edge respiratory devices and equipment, including high-performance ventilators, nebulizers, and portable oxygen concentrators, has not only improved the quality of patient care but has also significantly enhanced the efficiency and effectiveness of healthcare delivery in the field of respiratory medicine. Moreover, the integration of technology in telemedicine and remote monitoring solutions has gained considerable prominence, enabling healthcare providers to offer continuous care and remotely monitor patients' respiratory health, thus reducing the need for frequent in-person visits. Artificial intelligence (AI) and machine learning are also playing an increasingly critical role in respiratory diagnostics, offering more streamlined healthcare processes, improved accuracy, and personalized treatment recommendations, ultimately driving market growth.

Market Challenges

Healthcare Disparities: One of the central challenges facing the global respiratory market is the existence of healthcare disparities. Access to quality respiratory care varies significantly between different regions, with some areas struggling with shortages of healthcare professionals, equipment, and facilities. Low- and middle-income countries, in particular, often find it challenging to provide adequate respiratory care, resulting in higher mortality rates and an increased disease burden. Addressing these disparities and ensuring that all individuals, regardless of their geographic location or socioeconomic status, have access to essential respiratory services and treatments is a critical challenge that requires international cooperation and substantial investment in healthcare infrastructure and resources.

Rising Healthcare Costs: The escalating costs associated with respiratory care pose a substantial challenge to both healthcare providers and patients. Respiratory disorders often necessitate long-term management, including the use of expensive medications, specialized equipment, and regular medical check-ups, all of which can place a considerable financial burden on individuals and healthcare systems. Striking the right balance between the need for cutting-edge, albeit costly, respiratory technologies and the financial constraints faced by healthcare systems is an ongoing challenge that the industry must confront.

Market Trends

Telemedicine and Remote Monitoring: Telemedicine and remote monitoring have emerged as major trends in the global respiratory market. These technologies are transforming the delivery of respiratory care by enabling real-time monitoring of patients' lung function and health status from a distance. The integration of remote consultations with digital devices that track essential respiratory metrics offers patients greater convenience, while providing healthcare providers with a more efficient means of managing chronic respiratory conditions. These trends are expected to persist, driven by ongoing advancements in wearable technology, the need for social distancing measures during health crises such as the COVID-19 pandemic, and the growing emphasis on patient-centered care in respiratory medicine.

Personalized and Precision Medicine: The trend toward personalized and precision medicine is making significant inroads in respiratory care. By leveraging genetic information, advanced diagnostic tools, and cutting-edge treatments, healthcare providers can tailor treatment plans to individual patients, leading to improved outcomes and a reduction in adverse effects. This approach allows for more accurate disease management, as well as the identification of specific risk factors for respiratory disorders. As genomics and molecular biology continue to advance, the integration of personalized and precision medicine into respiratory care is expected to expand, revolutionizing how respiratory conditions are diagnosed and treated. This trend has the potential to significantly enhance the quality of respiratory care and improve patient outcomes in the long term.

Covid-19 Impacts

The global Respiratory Care Market experienced a significant impact as a result of the COVID-19 pandemic. The surge in COVID-19 cases led to a sudden and unprecedented demand for respiratory care equipment and services. Hospitals and healthcare facilities across the world faced overwhelming challenges as they grappled with the need for ventilators, oxygen therapy devices, and other respiratory care equipment to treat severe cases of the virus. This surge in demand strained the supply chain and led to shortages in critical equipment. Additionally, the pandemic prompted a surge in telehealth services, including remote monitoring of respiratory conditions, to reduce in-person medical visits and minimize the risk of virus transmission. The pandemic underscored the critical importance of respiratory care and has prompted increased investment in research and development, which is likely to drive innovation and growth in the respiratory care market in the post-pandemic era. The COVID-19 pandemic serves as a stark reminder of the vital role that respiratory care plays in public health and has accelerated the adoption of telehealth and digital solutions in respiratory care delivery.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Respiratory care devices market Outlook with its value and forecast along with its segments
• Region & Country-wise Respiratory care devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa

By Product Type:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:

• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:

• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.